Diamond, Gems and Jewellery · GLDM:
Lab Grown Diamonds
from 368 today
Goldiam International delivered a stellar Q1FY27 performance with strong B2B export momentum and robust lab-grown diamond jewellery demand. We roll forward to Q1FY29E and value the stock at 30x EPS, arriving at a TP of Rs 470.
Goldiam International delivered a stellar Q1FY27 performance, with revenue materially ahead of our estimates, reinforcing the strength of its core B2B export franchise and the structural opportunity in lab-grown diamond jewellery. We expect healthy growth over FY26-29E, led by robust momentum in the B2B export business, while ORIGEM should follow a more calibrated expansion strategy focused on store productivity and profitability.
Ratings and target prices as published by each firm. Each summary condenses that firm's stated view in its own note and is attributed to it; no report text is reproduced.
